Bangalore, India -- (SBWIRE) -- 05/24/2017 -- General Report Contents
- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions

The EEG market is made up of clinical EEG monitors, long-term EEG monitors, and ICU monitors. Clinical EEG monitoring equipment represented the single largest segment followed by long-term EEG monitors and ICU EEG segments.
Presently, the clinical EEG market accounts for the majority of the diagnostic EEG market revenue. However, over the forecast period the long-term monitoring segment will strengthen further to represent a larger share of the total market, eating away at the market share of clinical EEG monitors. This shift is driven in part by the high costs associated with the feature loaded monitor configurations utilized in non-routine settings. Furthermore, the deployment of new, high-end technologies, including source imaging and dense array EEG, in addition to expanded applications for EEG will facilitate further revenue growth across these developing EEG device markets.

Future growth within the total EEG market is attributable to a number of factors: Patient outcome benefits resulting from earlier EEG-based detections and interventions are being realized and will drive greater EEG use, particularly in the context of epilepsy monitoring. Expansion of signal interpretation services and technological advancements improving usability will make EEG diagnostics more accessible and increase adoption in both acute and sub-acute care settings. Finally, the aging population and increase in the prevalence of neurological and mental disorders will prompt an expansion of EEG procedural volumes.

The diagnostic EEG market has been expanding significantly with revenue growth driven largely by the ICU monitor, long-term monitor, and, to a lesser extent, clinical EEG segment since this market is already mature and will not be very active outside of replacement-driven sales.

Electroencephalography (EEG) devices record the electrical activity of neurons in the brain through electrodes placed on the scalp (non-invasive) or directly on the brain (invasive). EEG is commonly used for diagnosing seizures, comas and other brain abnormalities. The efficacy of EEG in the identification of treatable etiologies of altered mental status (AMS) continues to be a major focus for research efforts.

Spanning over 204 pages "Australia Market Report for Electroencephalogram Monitoring and Diagnostics 2017 - MedCore" report covers Executive Summary, Australia Market For Patient Monitoring Equipment Overview, Competitive Analysis, Market Trends, Market Developments, Research Methodology, Product Assessment, Electroencephalogram Monitoring And Diagnostic Market, Appendix. The report covered companies are - Philips Healthcare, GE Healthcare, Medtronic, Omron Healthcare, Masimo, Draeger Medical, Welch Allyn, Tunstall Healthcare, Boston Scientific, Mindray, St. Jude Medical

For more information Visit at: http://www.drugpipeline.net/idata-research/australia-market-report-electroencephalogram-monitoring-and-diagnostics-2017-medcore

Related Report:

South Korea Market Report for Electroencephalogram Monitoring and Diagnostics 2017 - MedCore: visit at - http://www.drugpipeline.net/idata-research/south-korea-market-report-electroencephalogram-monitoring-and-diagnostics-2017

Find all Medical Devices Reports at - http://www.drugpipeline.net/catalog/medical-devices

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.